Online inquiry

IVTScrip™ mRNA-Human ASB9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26901MR)

This product GTTS-WK26901MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASB9 protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001031739.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 140462
UniProt ID Q96DX5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB9, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26901MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19712MR IVTScrip™ mRNA-Human ANKRD26P3, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKRD26P3
GTTS-WK23207MR IVTScrip™ mRNA-Human ARHGEF10, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF10
GTTS-WK21734MR IVTScrip™ mRNA-Human ARL13B, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ARL13B
GTTS-WK6227MR IVTScrip™ mRNA-Human CD24, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA CD24
GTTS-WK28401MR IVTScrip™ mRNA-Human ASB9, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ASB9
GTTS-WK18834MR IVTScrip™ mRNA-Human ANKRD65, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD65
GTTS-WK22968MR IVTScrip™ mRNA-Human ARPC3, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARPC3
GTTS-WK22014MR IVTScrip™ mRNA-Human ARHGEF26, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF26
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW